These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 336116)

  • 1. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia.
    Sawitsky A; Rai KR; Glidewell O; Silver RT
    Blood; 1977 Dec; 50(6):1049-59. PubMed ID: 336116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.
    Montserrat E; Alcalá A; Parody R; Domingo A; García-Conde J; Bueno J; Ferrán C; Sanz MA; Giralt M; Rubio D
    Cancer; 1985 Nov; 56(10):2369-75. PubMed ID: 3899346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy. A Southeastern Cancer Study Group Trial.
    Keller JW; Knospe WH; Raney M; Huguley CM; Johnson L; Bartolucci AA; Omura GA
    Cancer; 1986 Sep; 58(6):1185-92. PubMed ID: 3527402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentostatin, chlorambucil and prednisone therapy for B-chronic lymphocytic leukemia: a phase I/II study by the Eastern Cooperative Oncology Group study E1488.
    Oken MM; Lee S; Kay NE; Knospe W; Cassileth PA
    Leuk Lymphoma; 2004 Jan; 45(1):79-84. PubMed ID: 15061201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of early chronic lymphocytic leukemia: intermittent chlorambucil versus observation.
    Shustik C; Mick R; Silver R; Sawitsky A; Rai K; Shapiro L
    Hematol Oncol; 1988; 6(1):7-12. PubMed ID: 3277904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
    Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
    J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCI CLL-01 trial.
    Jaksić B; Brugiatelli M
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):437-42. PubMed ID: 3065740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent combination chemotherapy with chlorambucil and prednisone of low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification.
    Stolzenbach G; Garbrecht M
    J Cancer Res Clin Oncol; 1979 Feb; 93(2):189-94. PubMed ID: 438282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia.
    Han T; Ezdinli EZ; Shimaoka K; Desai DV
    Cancer; 1973 Mar; 31(3):502-8. PubMed ID: 4693581
    [No Abstract]   [Full Text] [Related]  

  • 11. [Present status of chemotherapy in ALL and CLL].
    Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1882-7. PubMed ID: 6964032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
    J Natl Cancer Inst; 1999 May; 91(10):861-8. PubMed ID: 10340906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of 2-chlorodeoxyadenosine in combination with chlorambucil in previously untreated B-cell chronic lymphocytic leukemia.
    Tefferi A; Levitt R; Li CY; Schroeder G; Tschetter LK; Michalak JC; Krook JE; Witzig TE
    Am J Clin Oncol; 1999 Oct; 22(5):509-16. PubMed ID: 10521069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparison of total body irradiation vs chlorambucil and prednisone for remission induction of active chronic lymphocytic leukemia: an ECOG study. Part I: total body irradiation-response and toxicity.
    Rubin P; Bennett JM; Begg C; Bozdech MJ; Silber R
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1623-32. PubMed ID: 7037702
    [No Abstract]   [Full Text] [Related]  

  • 17. Fatal interstitial pneumonitis following high-dose intermittent chlorambucil therapy for chronic lymphocyte leukemia.
    Lane SD; Besa EC; Justh G; Joseph RR
    Cancer; 1981 Jan; 47(1):32-6. PubMed ID: 7459812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial.
    Robak T; Bloński JZ; Kasznicki M; Blasińska-Morawiec M; Krykowski E; Dmoszyńska A; Mrugala-Spiewak H; Skotnicki AB; Nowak W; Konopka L; Ceglarek B; Maj S; Dwilewicz-Trojaczek J; Hellmann A; Urasiński I; Zdziarska B; Kotlarek-Haus S; Potoczek S; Grieb P
    Blood; 2000 Oct; 96(8):2723-9. PubMed ID: 11023504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term evaluation of chlorambucil plus prednisone in the idiopathic nephrotic syndrome of childhood.
    Williams SA; Makker SP; Ingelfinger JR; Grupe WE
    N Engl J Med; 1980 Apr; 302(17):929-33. PubMed ID: 6987521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group.
    Panovská A; Němcová L; Nekvindová L; Špaček M; Šimkovič M; Papajík T; Brejcha M; Lysák D; Zuchnická J; Novák J; Starostka D; Poul H; Vrbacký F; Vodárek P; Urbanová R; Plevová K; Pospíšilová Š; Mašlejová S; Brychtová Y; Koriťáková E; Smolej L; Doubek M
    Hematol Oncol; 2020 Oct; 38(4):509-516. PubMed ID: 32400885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.